causal
Analysis v1
Strong Support
For people with heart disease who are already taking cholesterol-lowering drugs, adding a medicine called evolocumab can cut their risk of heart attack, stroke, or dying from heart problems by 20% over about two years.
74
0
Evidence from Studies
Supporting (1)
74
Community contributions welcome
74
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Randomized Controlled Trial
Human
2017 May 4The study gave evolocumab to heart disease patients already on statins and found it lowered their risk of heart attack, stroke, or dying from heart problems by 20%, just like the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.